| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/16/2009 | CN101530502A Traditional Chinese medicine for treating diabetic fundus hemorrhage |
| 09/16/2009 | CN101530501A Traditional Chinese medicine for treating diabetic anemia |
| 09/16/2009 | CN101530497A Extract and composition of rutaceae zanthoxylum peel, preparing method and application thereof |
| 09/16/2009 | CN101530479A Traditional Chinese medicine for treating diabetes mellitus complicated by muscle atrophy |
| 09/16/2009 | CN101530469A Method for preparing effective component group of water soluble Chinese cassia tree |
| 09/16/2009 | CN101530466A Nano medicament containing oregano oil and vitamins |
| 09/16/2009 | CN101530459A Application of licorice flavones preparation |
| 09/16/2009 | CN101530440A Oral pharmaceutical preparation of aralia elata total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530432A Method for producing degreased concentrated solution of tussah male moth |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN101530429A New use of clarias lazera |
| 09/16/2009 | CN101530421A A Bianque stone paste and a preparation method thereof |
| 09/16/2009 | CN101530415A Pharmaceutical composition containing bisphosphates and preparation method thereof |
| 09/16/2009 | CN101530390A Preparation of Alpha-linolenic acid nanoliposome preparation and prescription |
| 09/16/2009 | CN101530204A Crisp candy suitable for diabetes patients |
| 09/16/2009 | CN101530200A Formula of donkey-hide glue combined hearth-care series products and preparation method thereof |
| 09/16/2009 | CN100540666C Method for producing human insulin by transgenic romaine lettuce, tomato and tobacco |
| 09/16/2009 | CN100540570C Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540537C Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 09/16/2009 | CN100540016C Fat-reducing speckle-removing cosmetic mixture and its capsule |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/15/2009 | US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588782 Rare earth metal compositions for treating hyperphosphatemia and related methods |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2533784C Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 09/15/2009 | CA2467805C Novel chromium (iii) alpha amino acid complexes |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2439879C C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/15/2009 | CA2415065C Oral compositions comprising host-response modulating agent |
| 09/15/2009 | CA2376835C Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2359463C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2294086C Palatable elemental medical food |
| 09/15/2009 | CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009111611A2 Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
| 09/11/2009 | WO2009111078A2 Combination of a ppary agonist and a dipeptidyl peptidase-inhibitor for the treatment of diabetes and obesity |
| 09/11/2009 | WO2009111056A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | WO2009110646A1 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 09/11/2009 | WO2009110612A1 New compound derived from germinated brown rice, and agent containing said compound as an active ingredient for prevention or amelioration of neuropathy |
| 09/11/2009 | WO2009110546A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same |
| 09/11/2009 | WO2009110520A1 Heterocyclic compound |
| 09/11/2009 | WO2009110510A1 Alkylaminopyridine derivative |
| 09/11/2009 | WO2009110504A1 Soybean protein material for patients with renal disease and foods made from the same |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110464A1 Composition for improvement in nutrition |
| 09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
| 09/11/2009 | WO2009109999A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109998A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109710A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 09/11/2009 | WO2009109654A2 Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | WO2009109643A2 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | WO2009109616A2 Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109270A1 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
| 09/11/2009 | WO2009109259A1 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | WO2009109258A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | WO2009053980A3 An improved appetite suppressant |
| 09/11/2009 | WO2009040069A3 Use of bq-610 alone or in combination with helodermin as a therapeutic agent |
| 09/11/2009 | WO2009033779A3 Nociceptin for use as a therapeutic agent |
| 09/11/2009 | WO2009033778A3 Mage-3 antigen and others for use as a therapeutic agent |
| 09/11/2009 | WO2009033775A3 Peptide alpmhir alone or in combination with peptide yvpfppf as therapeutic agent |
| 09/11/2009 | WO2009033732A3 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 09/11/2009 | WO2009033726A3 Use of cart (55-102), optionally in combination with tuftsin, as a therapeutic agent |
| 09/11/2009 | WO2009033683A3 Galanin message associated peptide alone or in combination with minigastrin as a therapeutic agent |
| 09/11/2009 | WO2008125928A3 Standardized bioactive extracts of annona squamosa |
| 09/11/2009 | WO2008001931A3 Fused cyclic compounds |
| 09/11/2009 | WO2006021006A3 Non-human animal models for diabetic complications and their uses |
| 09/11/2009 | CA2717753A1 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717718A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717518A1 Pyrrolidine derivatives |
| 09/11/2009 | CA2717287A1 5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes type 1 and 2 |
| 09/11/2009 | CA2717138A1 Heterocyclic compound |
| 09/11/2009 | CA2717108A1 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | CA2716664A1 Oxadiazoanthracene compounds for the treatment of diabetes |
| 09/11/2009 | CA2716352A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | CA2716130A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | CA2715065A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | CA2714617A1 Alkylaminopyridine derivative |
| 09/11/2009 | CA2714436A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | CA2712921A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227679 Novel NIDDM Regimen |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227647 Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes |
| 09/10/2009 | US20090227631 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
| 09/10/2009 | US20090227597 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227588 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors |
| 09/10/2009 | US20090227576 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 09/10/2009 | US20090227569 Pyrrolidine derivatives |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |